Pharmacogenomics Technology Theranostics Companion Diagnostics Market

List of Tables
Table 1. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of PCR
Table 3. Key Players of In-situ Hybridization
Table 4. Key Players of Immunohistochemistry
Table 5. Key Players of Sequencing
Table 6. Key Players of Others
Table 7. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Region (2017-2022)
Table 11. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Region (2023-2028)
Table 13. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Trends
Table 14. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Drivers
Table 15. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Challenges
Table 16. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Restraints
Table 17. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Share by Players (2017-2022)
Table 19. Global Top Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) as of 2021)
Table 20. Ranking of Global Top Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product Solution and Service
Table 24. Date of Enter into Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Market Share by Type (2017-2022)
Table 28. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Market Share by Type (2023-2028)
Table 30. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Share by Application (2017-2022)
Table 32. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Share by Application (2023-2028)
Table 34. North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2023-2028) & (US$ Million)
Table 64. Qiagen NV Company Details
Table 65. Qiagen NV Business Overview
Table 66. Qiagen NV Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product
Table 67. Qiagen NV Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022) & (US$ Million)
Table 68. Qiagen NV Recent Developments
Table 69. GE Healthcare Company Details
Table 70. GE Healthcare Business Overview
Table 71. GE Healthcare Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product
Table 72. GE Healthcare Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022) & (US$ Million)
Table 73. GE Healthcare Recent Developments
Table 74. Agilent Technologies Company Details
Table 75. Agilent Technologies Business Overview
Table 76. Agilent Technologies Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product
Table 77. Agilent Technologies Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022) & (US$ Million)
Table 78. Agilent Technologies Recent Developments
Table 79. F Hoffman La Roche Company Details
Table 80. F Hoffman La Roche Business Overview
Table 81. F Hoffman La Roche Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product
Table 82. F Hoffman La Roche Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022) & (US$ Million)
Table 83. F Hoffman La Roche Recent Developments
Table 84. Foundation Medicine Company Details
Table 85. Foundation Medicine Business Overview
Table 86. Foundation Medicine Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product
Table 87. Foundation Medicine Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022) & (US$ Million)
Table 88. Foundation Medicine Recent Developments
Table 89. Thermo Fisher Scientific Inc. Company Details
Table 90. Thermo Fisher Scientific Inc. Business Overview
Table 91. Thermo Fisher Scientific Inc. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product
Table 92. Thermo Fisher Scientific Inc. Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022) & (US$ Million)
Table 93. Thermo Fisher Scientific Inc. Recent Developments
Table 94. Leica Biosystems Nussloch GmBH Company Details
Table 95. Leica Biosystems Nussloch GmBH Business Overview
Table 96. Leica Biosystems Nussloch GmBH Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product
Table 97. Leica Biosystems Nussloch GmBH Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022) & (US$ Million)
Table 98. Leica Biosystems Nussloch GmBH Recent Developments
Table 99. Pfizer Company Details
Table 100. Pfizer Business Overview
Table 101. Pfizer Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product
Table 102. Pfizer Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022) & (US$ Million)
Table 103. Pfizer Recent Developments
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Type: 2021 VS 2028
Figure 2. PCR Features
Figure 3. In-situ Hybridization Features
Figure 4. Immunohistochemistry Features
Figure 5. Sequencing Features
Figure 6. Others Features
Figure 7. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Application: 2021 VS 2028
Figure 8. Oncology Case Studies
Figure 9. Neurological Disorders Case Studies
Figure 10. Cardiovascular Disease Case Studies
Figure 11. Immunological Disorders Case Studies
Figure 12. Others Case Studies
Figure 13. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Report Years Considered
Figure 14. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 15. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Region: 2021 VS 2028
Figure 17. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Players in 2021
Figure 18. Global Top Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue in 2021
Figure 20. North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY (2017-2028) & (US$ Million)
Figure 21. North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Type (2017-2028)
Figure 22. North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Application (2017-2028)
Figure 23. North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Share by Country (2017-2028)
Figure 24. United States Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Canada Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY (2017-2028) & (US$ Million)
Figure 27. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Type (2017-2028)
Figure 28. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Application (2017-2028)
Figure 29. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Share by Country (2017-2028)
Figure 30. Germany Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. France Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. U.K. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Italy Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Russia Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Nordic Countries Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Asia-Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY (2017-2028) & (US$ Million)
Figure 37. Asia Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Type (2017-2028)
Figure 38. Asia Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Application (2017-2028)
Figure 39. Asia Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Share by Region (2017-2028)
Figure 40. China Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Japan Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. South Korea Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Southeast Asia Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. India Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Australia Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 46. Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY (2017-2028) & (US$ Million)
Figure 47. Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Type (2017-2028)
Figure 48. Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Application (2017-2028)
Figure 49. Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Share by Country (2017-2028)
Figure 50. Mexico Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Brazil Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY (2017-2028) & (US$ Million)
Figure 53. Middle East and Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Type (2017-2028)
Figure 54. Middle East and Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Application (2017-2028)
Figure 55. Middle East and Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Share by Country (2017-2028)
Figure 56. Turkey Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Saudi Arabia Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. UAE Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 59. Qiagen NV Revenue Growth Rate in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
Figure 60. GE Healthcare Revenue Growth Rate in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
Figure 61. Agilent Technologies Revenue Growth Rate in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
Figure 62. F Hoffman La Roche Revenue Growth Rate in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
Figure 63. Foundation Medicine Revenue Growth Rate in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
Figure 64. Thermo Fisher Scientific Inc. Revenue Growth Rate in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
Figure 65. Leica Biosystems Nussloch GmBH Revenue Growth Rate in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
Figure 66. Pfizer Revenue Growth Rate in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed